Analyze Diet
Veterinary clinical pathology2013; 42(2); 184-189; doi: 10.1111/vcp.12038

Validation of the IDS Octeia ELISA for the determination of insulin-like growth factor 1 in equine serum and tendon tissue extracts.

Abstract: Insulin-like growth factor (IGF-1) is an important mediator of tissue repair in horses. Objective: The aim of the study was to evaluate whether IGF-1 could be measured reliably in equine serum and tendon tissue extracts, using an IGF-1 ELISA kit developed for human serum and plasma. Methods: A glycyl-glycine pretreatment protocol of samples was compared with the pretreatment procedure recommended by the manufacturer. Intra- and inter-assay imprecision were evaluated by repeated measurements of equine serum pools. Assay inaccuracy was determined based on the linearity of serially diluted equine serum samples and tendon tissue extracts. The recovery of IGF-1 was evaluated in serum and tendon tissue extracts spiked with known amounts of IGF-1. Results: The range of IGF-1 released using the manufacturer's pretreatment was between 23% and 56% of the amount released using the gly-gly pretreatment in different equine samples. In serum pools with low, intermediate, and high IGF-1 concentrations, intra-assay imprecision was 4.0%, 4.0%, and 3.1%, respectively, and inter-assay imprecision was 13.9%, 7.3%, and 12.8%, respectively. The recovery of serially diluted serum was 96 ± 3% when diluted with serum, and 72 ± 15% when diluted with PBS. The recovery after dilution was 108 ± 17% in tendon tissue extracts. Recovery from serum spiked with a fixed amount of IGF-1 was 101 ± 5% and 99 ± 7% from tendon tissue samples. Conclusions: The IDS Octeia IGF-1 ELISA kit can be used for measuring IGF-1 in equine serum and tendon tissue extract after pretreatment with glycyl-glycine.
Publication Date: 2013-04-23 PubMed ID: 23647259DOI: 10.1111/vcp.12038Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Validation Study

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research aims to validate the use of the IDS Octeia ELISA kit, initially developed for humans, to measure Insulin-like growth factor 1 (IGF-1), a critical tissue repair agent, in horses’ blood serum and tendon tissue. The study establishes the accuracy and reliability of the kit after a specific pretreatment procedure using glycyl-glycine.

Methods

  • The research involves comparing the glycyl-glycine pretreatment protocol to the manufacturer’s recommended pretreatment procedure to see which one resulted in an accurate measurement of IGF-1 in equine serum and tendon tissue extracts.
  • Intra-assay and inter-assay imprecision were evaluated through repeated measurements performed on equine serum pools. Intra-assay refers to the variability of outcomes within one test series, while inter-assay involves variability between different series.
  • The researchers checked the inaccuracy of the assay by determining the linearity of diluted equine serum samples and tendon tissue extracts.
  • The recovery of IGF-1, or the ability to measure it from serum and tissue extracts spiked with known amounts of IGF-1, was also evaluated. This determines the assay’s performance and efficiency.

Results

  • The results showed that the IGF-1 released using the manufacturer’s pretreatment procedure was between 23% and 56% of the amount released using the glycyl-glycine pretreatment.
  • The intra- and inter-assay imprecision ranged from 3.1% to 4.0%, and 7.3% to 13.9% respectively, which indicates high precision of the ELISA kit.
  • The recovery rates from diluted serum samples were above 70% whether diluted with serum or PBS and reached 108% in tendon tissue extracts, demonstrating the accuracy and reliability of the ELISA kit in measurement of IGF-1.

Conclusions

  • The study’s findings support the use of the IDS Octeia ELISA kit for measuring IGF-1 in equine serum and tendon tissue extracts when pretreated with glycyl-glycine. This makes it a useful and reliable tool for research in equine medicine and biochemistry.

Cite This Article

APA
Lygren T, Schjerling P, Jacobsen S, Berg LC, Nielsen MO, Langberg H, Thomsen PD. (2013). Validation of the IDS Octeia ELISA for the determination of insulin-like growth factor 1 in equine serum and tendon tissue extracts. Vet Clin Pathol, 42(2), 184-189. https://doi.org/10.1111/vcp.12038

Publication

ISSN: 1939-165X
NlmUniqueID: 9880575
Country: United States
Language: English
Volume: 42
Issue: 2
Pages: 184-189

Researcher Affiliations

Lygren, Tone
  • Department of Basic Animal and Veterinary Sciences, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark.
Schjerling, Peter
    Jacobsen, Stine
      Berg, Lise C
        Nielsen, Mette O
          Langberg, Henning
            Thomsen, Preben D

              MeSH Terms

              • Animals
              • Enzyme-Linked Immunosorbent Assay / veterinary
              • Horses / blood
              • Horses / metabolism
              • Insulin-Like Growth Factor I / analysis
              • Insulin-Like Growth Factor I / metabolism
              • Protein Binding
              • Reagent Kits, Diagnostic / veterinary
              • Reproducibility of Results
              • Tendons / chemistry
              • Tendons / metabolism
              • Tissue Extracts / chemistry
              • Tissue Extracts / metabolism

              Citations

              This article has been cited 1 times.
              1. Wang M, Zhang J, Li H, Li Y, Li Z. Insulin-like growth factor-1 (IGF-1) empowering tendon regenerative therapies. Front Bioeng Biotechnol 2025;13:1492811.
                doi: 10.3389/fbioe.2025.1492811pubmed: 40213631google scholar: lookup